Revvity (NYSE:RVTY – Get Free Report) and Evotec (NASDAQ:EVO – Get Free Report) are both healthcare companies, but which is the better business? Get Revvity alerts:Net Margins Return on Equity Return on Assets Revvity 8.16% 8.34% 5.01% Evotec -26.20% -24.93% -11.35%Analyst RatingsThis is a breakdown of current ratings and price targets for Revvity and Evotec, as reported by MarketBeat.com. Revvity has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Evotec has a beta of 1.96, suggesting that its share price is 96% more volatile than the S&P 500. Institutional & Insider Ownership86.7% of Revvity shares are held by institutional investors.